{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-039745","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.431280+00:00","generated_at":"2026-06-08T17:49:55.965697+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Mangoceuticals (MGRX) gets Nasdaq notice for equity of $1.35M vs $2.5M minimum","bullets":["Stockholders' equity of $1,354,821 as of Sep 30, 2023, below Nasdaq's $2.5M continued listing requirement.","Must submit a compliance plan by Dec 18, 2023; Nasdaq may grant up to 180-day extension if plan accepted.","Company also not in compliance with minimum bid price of $1.00 per share, previously reported.","Failure to regain compliance could result in delisting; management is evaluating options to address the deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-039745","json":"https://secwatch.observer/filing/0001493152-23-039745.json","markdown":"https://secwatch.observer/filing/0001493152-23-039745.md","text":"https://secwatch.observer/filing/0001493152-23-039745.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/0001493152-23-039745-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T17:49:55.965697+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"63020a7a55cc0081f476b55d759c01ae476442c1","claim":"MANGOCEUTICALS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000. In the Company’s Form 10-Q, the Company reported stockholders’ equity of $1,354,821, which is below the minimum stockholders’ equity required for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1). Additionally, as of the date of this Report, the Company","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/0001493152-23-039745-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}